Status: current, Defined. Date: 31-Jul 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2433591000168118 | Hadlima (adalimumab 40 mg / 0.8 mL) injection, 0.8 mL syringe (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2433601000168113 | Hadlima 40 mg/0.8 mL injection, 0.8 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hadlima 40 mg/0.8 mL injection, 0.8 mL syringe | Is a | Hadlima | true | Inferred relationship | Some | ||
| Hadlima 40 mg/0.8 mL injection, 0.8 mL syringe | Is a | adalimumab 40 mg/0.8 mL injection, syringe | true | Inferred relationship | Some | ||
| Hadlima 40 mg/0.8 mL injection, 0.8 mL syringe | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Hadlima 40 mg/0.8 mL injection, 0.8 mL syringe | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Hadlima 40 mg/0.8 mL injection, 0.8 mL syringe | has unit of use | syringe | true | Inferred relationship | Some | 1056744125 | |
| Hadlima 40 mg/0.8 mL injection, 0.8 mL syringe | has Australian BoSS | adalimumab | true | Inferred relationship | Some | 1056744124 | |
| Hadlima 40 mg/0.8 mL injection, 0.8 mL syringe | has intended active ingredient | adalimumab | true | Inferred relationship | Some | 1056744124 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Hadlima 40 mg/0.8 mL injection, 2 x 0.8 mL syringes | has TPUU | True | Hadlima 40 mg/0.8 mL injection, 0.8 mL syringe | Inferred relationship | Some | 1 |
| Hadlima 40 mg/0.8 mL injection, 2 x 0.8 mL syringes | has TPUU | True | Hadlima 40 mg/0.8 mL injection, 0.8 mL syringe | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR